Haberhausen, Gerd (Roche 201106 Life Cycler Leader qPCR + NA Preparation at Roche Applied Science) |
Product Manager (personnel) |
Roche (Group) |
United States (USA) |
Haberkamm, Petra (Lonza 201703 Manager Marketing Communcations at Lonza Cologne GmbH) |
Sales Manager / Marketing Manager |
Lonza (Group) |
Germany |
Haberstroh, Klaus (ESE GmbH 200909 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
Hacke, Werner (Lion 200603) |
Board member, non-executive |
Expedeon (Group) |
Germany |
Hackenberger, Alfred (BASF 1981–) |
n. a. |
BASF (Group) |
Germany |
Haddad, Isam (Metabolomic Discoveries 201501 Bioinformatics Expert) |
n. a. |
Metabolon (Group) |
Germany |
Hadvary, Paul (Arpida 200803 Head of Developm) |
n. a. |
Evolva (Group) |
Switzerland |
Haedo, Rodolfo (Nanion Technologies 201410 VP Nanion Technologies Inc) |
n. a. |
Nanion (Group) |
United States (USA) |
Haefele, Mark (UBS 201604 Global Chief Investment Officer at UBS Wealth Management) |
Investment Manager |
UBS (Group) |
Switzerland |
Haefeli, Roland (Actelion 201105 VP Head Investor Relations + Public Affairs) |
Public Relations Manager / Investor Relations Manager |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Haehl, Manfred (Boehringer 200905 Corrporate SVP Medicine) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
Haehner, Thomas (Acrovis 201110 Managing Director) |
Managing Director |
Acrovis Biostructures GmbH |
Germany |
Haerst, Miriam (Kumovis 202005 Managing Director + Co-Founder) |
Managing Director |
Kumovis GmbH |
Germany |
Hafen, Ernst (EvalueScience 201104 CEO + Genetics Co + ETH Zürich) |
Chief Executive Officer (CEO) |
EvalueScience Ltd. |
Switzerland |
Hafenbradl, Doris (Axxam 201411 VP Discovery Services) |
President/Director/Head Business Group/Unit/Division |
Axxam S.p.A. |
Italy |
Haferlach, Torsten (MLL Münchner Leukämielabor 201212 Managing Director (CEO)) |
Managing Director |
MLL Münchner Leukämielabor GmbH |
Germany |
Hafseth, James (Miltenyi Biotec 202001 Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Miltenyi Biotec (Group) |
Germany |
Hagedorn, Thomas (Bruker 201403 Product Manager at Bruker Daltonics) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
Hagel, Kathrin (Messe München 201105 Press Office Analytica) |
Public Relations Manager / Investor Relations Manager |
Messe München GmbH |
Germany |
Hagen, Alexander (Synlab 201603 Group Head of Marketing + Communications) |
Sales Manager / Marketing Manager |
Synlab (Group) |
Germany |
Hagen, Christa (NewCo Pharma GmbH 201501– Managing Director) |
Managing Director |
NewCo Pharma GmbH (New Compounding Pharma GmbH) |
Germany |
Hagenhoff, Birgit (Tascon GmbH 201108 Managing Director) |
Managing Director |
Tascon Gesellschaft für Oberflächen und Materialcharakterisierung mbH |
Germany |
Hager, Gerhard (Aurigon Life Science GmbH 201412 Managing Director) |
Managing Director |
Aurigon Life Science GmbH |
Germany |
Hager, Gundel (WuXi PharmaTec 201912 Managing Director at Crelux) |
Managing Director |
WuXi PharmaTech (Group) |
Germany |
Haghdoost, Navid (Thermo Fisher 201705 Director Protein Biology Product Management) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
Hahn, Alfred (AbbVie 201503 Senior Director + Head of Discovery) |
Research & Development Manager |
AbbVie (Group) |
United States (USA) |
Hahn, Horst Karl (Fraunhofer MEVIS 200904 Deputy Institute Director) |
n. a. |
Fraunhofer (Group) |
Germany |
Hahne, Hannes (OmicScouts GmbH 201407– Managing Director + Co-Founder) |
Managing Director |
OmicScouts GmbH |
Germany |
Haigh, Adrian (Gentium 201201 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Jazz Pharmaceuticals (Group) |
Italy |
Haigh, Brantley (Proteros 201008– Business Development US West Coast working for Proteros since 4 years) |
Business Development Manager / Strategy Manager |
Proteros (Group) |
United States (USA) |
Haigh, Robert (Macomics 202007– CEO + Executive Chair of Ikarovec before Ferring + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Macomics Ltd. |
United Kingdom (GB) |
Hain, David (Hain Lifesience 201808 Managig Director + Co-Founder) |
Managing Director |
Bruker (Group) |
Germany |
Hain, Tobias (Hain Lifesience 201808 Managig Director + Co-Founder) |
Managing Director |
Bruker (Group) |
Germany |
Haines, James R. (Berthold Detection Systems 200807 CEO of Titertek Instruments) |
Chief Executive Officer (CEO) |
Berthold Detection Systems (Group) |
United States (USA) |
Hajslova, Jana (Institute of Chemical Technology 201009 Professor Dept Food Chemistry and Analysis) |
Professor |
UCT Prague (University of Chemistry and Technology Prague, VSCHT) |
Czech Republic |
Halazonetis, Thanos (Univ Geneva 202004 Professor) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
Halbert, David D. (Caris Life Sciences 201303 CEO) |
Chief Executive Officer (CEO) |
Caris Life Sciences (Group) |
United States (USA) |
Halioua, Eric (PDC*line Pharma 201612– CEO before Promethera 200906– CEO) |
Chief Executive Officer (CEO) |
PDC*line Pharma (Group) |
Belgium |
Hall, Bridget (Fujifilm 201310 Communications Manager at Fujifilm Diosynth Biotechnologies UK Ltd) |
Public Relations Manager / Investor Relations Manager |
Fujifilm (Group) |
United Kingdom (GB) |
Hall, Matthew (Oncimmune 201906 CFO + 201904– Managing Director at Oncimmune Germany GmbH) |
Chief Financial Officer (CFO) |
Oncimmune (Group) |
United Kingdom (GB) |
Hall, Matthew (SimplicityBio SA 201610 CSO + Co-Founder) |
n. a. |
SimplicityBio S.A. |
Switzerland |
Hall, Sejal (Sonoma Biotherapeutics 202009– VP Program + Portfolio + Alliance Management before Audentes Tx + Denali Tx) |
Business Development Manager / Strategy Manager |
Sonoma Biotherapeutics Inc. |
United States (USA) |
Hallek, Michael |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Haller, Hermann |
n. a. |
Epoplus GmbH & Co. KG |
Germany |
Hallett, David (Exscientia 202001–COO before Evotec + Merck & Co) |
Chief Operating Officer (COO) |
Exscientia (Group) |
United Kingdom (GB) |
Haltermann, Kerstin |
n. a. |
Bremen (govt region) |
Germany |
Halwachs, Peter (Austria (govt) 201310 Managing Direcor of LISAvienna) |
Managing Director |
Austria (govt) |
Austria |
Hamacher, Christiane (Biocon 201910 CEO of Biocon Biologics) |
Chief Executive Officer (CEO) |
Biocon (Group) |
United Kingdom (GB) |
Hamann, Jens (PerkinElmer 200809 PerkinElmer LAS Germany) |
Sales Manager / Marketing Manager |
M2-Automation Martin Müller |
Germany |
Hambrecht, Jürgen (BASF AG 200501) |
n. a. |
BASF (Group) |
Germany |
Hambüchen, Klaus (Siemens 200903 Siemens Healthcare CEO Ultrasound) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
Hamester, Meike (Bruker 201302 Director ICP-MS Global Market Development + Product Management) |
Product Manager (personnel) |
Bruker (Group) |
|
Hamilton, Amanda (ADC Therapeutics 201911 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
|
|
Hamilton, Gregory (Greg) (Epigenomics 201607– CEO before AltheaDx + Enigma Diagnostics + Third Wave + Hologic) |
Chief Executive Officer (CEO) |
Epigenomics (Group) |
Germany |
Hamilton, Mark D. (Peak Scientific 201202– Managing Director of Peak Scientific Instruments GmbH) |
Managing Director |
Peak Scientific (Group) |
Germany |
Hammel, Oliver (DKSH 201904 Managing Director, Business Unit Technology, DKSH China) |
Managing Director |
DKSH (Group) |
Switzerland |
Hammer, Paul (Biomes NGS 202012 CEO + Founder) |
Chief Executive Officer (CEO) |
Biomes NGS GmbH |
Germany |
Hammond, Janet (Roche 201402 Head Infectious Disease at Roche pRED) |
Research & Development Manager |
Roche (Group) |
Switzerland |
Hampe, Jim (IFM Therapeutics 201610 SVP Business Development + Operations + Strategy) |
Business Development Manager / Strategy Manager |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
Hampl, Bernhard (Formycon 201403– Advisory Board Member former CEO of Eon Labs/Sandoz US) |
Advisory Board member |
Formycon (Group) |
Germany |
Han, Jason (SGS 201701 Managing Director of SGS Vietnam) |
Managing Director |
SGS (Group) |
Vietnam |
Hanan, Christopher C. (Tecan 2005– Senior VP BusDev + Corporate Communications joined Tecan 2004) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
Hanau, Götz (RWE 201710 Head of Strategy + Innovation at RWE Generation SE) |
Business Development Manager / Strategy Manager |
RWE (Group) |
Germany |
Haney, Bill (Skyhawk Therapeutics 201901 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Skyhawk Therapeutics (Group) |
United States (USA) |
Hangen, Frauke (BioRiver 201104 Managing Director) |
Managing Director |
BioRiver – Life Science im Rheinland e. V. |
Germany |
Hanisch, Carola (CEMIT 201105 Communication Manager) |
public relations / investor relations |
CEMIT – Center of Excellence in Medicine and IT GmbH |
Austria |
Hanke, Jeffrey (Jeff) (Tesaor 201506– CSO before Boehringer + AstraZeneca + Pfizer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GlaxoSmithKline (GSK) (Group) |
United States (USA) |
Hanke, Jens |
n. a. |
Robowatch Technologies GmbH |
Germany |
Hanke, Thomas (Evotec 201311– Head Immunology + Inflammation before Novo Nordisk + TeGenero) |
Research & Development Manager |
Evotec (Group) |
Germany |
Hanken, Thomas (Isitec 201109 Managing Director) |
Managing Director |
Isitec GmbH |
Germany |
Hannah, David (Link Technologies 201409 Head of Marketing) |
Sales Manager / Marketing Manager |
Link Technologies Ltd. |
United Kingdom (GB) |
Hannemann, Robert (MeVis Medical 201010– CFO) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
Hannus, Michael (SiTools Biotech GmbH 201504 Managing Director) |
Managing Director |
siTools Biotech GmbH |
Germany |
Hannus, Stefan (Intana Bioscience 201105 Managing Director) |
Managing Director |
Intana Bioscience GmbH |
Germany |
Hansel, Alfred (Oncgnostics GmbH 201204 Managing Director + Co-founder) |
Managing Director |
Oncgnostics GmbH |
Germany |
Hansen, Carl (AbCellera 201902 CEO) |
Chief Executive Officer (CEO) |
AbCellera Biologics Inc. |
Canada |
Hansen, David (MabVax Therapeutics 201807 CEO) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
United States (USA) |
Hansen, Dirk (Phenomenex 201003 Marketing Manager Europe) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
Hansen, Fabian (ANGERMAYER Group 202012 General Partner at Presight Capital) |
General Partner (venture partner) |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta |
Hansen, Gabriele (Evotec 201404 VP Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Evotec (Group) |
Germany |
Hansen, Jakob Dynnes (Acesion Pharma 201611– CFO before Evolva + Nuevolution + Zealand Pharma + Novo Nordisk) |
Chief Financial Officer (CFO) |
Evolva (Group) |
Switzerland |
Hansen, Jørgen (Evolva 201304–201712 promoted CSO before run Danish research TO STEP DOWN unitl end 2017) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evolva (Group) |
Switzerland |
Hansen, Rolf (Kreatech 201008– Director Marketing & Sales before Qiagen + Beckman Coulter + Miltenyi Biotec) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Netherlands |
Hantson, Ludwig Norbert Michel (Alexion 201703– CEO before Baxalta/Baxter) |
Chief Executive Officer (CEO) |
Alexion (Group) |
United States (USA) |
Haque, Imran (Freenome 201804 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Freenome Inc. |
United States (USA) |
Harada, Manabu (Filgen Inc 201404 Manager of Bioscience Dept) |
n. a. |
Filgen Inc. (JP) |
Japan |
Haran, Gilad (Weizmann Institute 201604 Prof + Dean of Faculty of Chemistry) |
Professor |
Weizmann Institute of Science |
Israel |
Harbort, Diana (Cassiopea 201507 CEO) |
Chief Executive Officer (CEO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
Hardas, Bhushan (Almirall 201809 EVP RnD + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Almirall (Group) |
Spain (España) |
Hardenbicker, Markus (GSK 201703 Head Corporate Communications at GlaxoSmithKline GmbH & Co KG) |
Public Relations Manager / Investor Relations Manager |
GlaxoSmithKline (GSK) (Group) |
Germany |
Harder, Alexander (Thermo Fisher 201607– Senior Platform Manger Exactive Series before Bruker Daltonik GmbH) |
Product Manager (personnel) |
Thermo Fisher (Group) |
Germany |
Hardung, Kerstin (Peqlab 200809) |
n. a. |
Avantor (Group) |
Germany |
Hardwick, Andy (Schauenburg 201912 Commercial Director at Schauenburg Analytics Ltd) |
Chief Commercial Officer (CCO) |
Schauenburg (Group) |
|
Hardwicke, David (Structured Immunity 201808 President + Co-Founder) |
n. a. |
Structured Immunity (US) |
United States (USA) |
Hardy, David (ACD/Labs 201404 MS Product Manager before Waters UK + Shimadzu UK) |
Product Manager (personnel) |
Advanced Chemistry Development (ACD/Labs) (Group) |
United Kingdom (GB) |
Harkins, Timothy (Swift Biosciences 201602 CEO) |
Chief Executive Officer (CEO) |
Hirtle, Callaghan & Co. |
United States (USA) |
Harland, Deborah (GSK 200904 Partner at SR One Ltd) |
Partner (venture partner) |
SR One (Group) |
United States (USA) |
Harmeier, Anja (Pueros Bioventures 202007 Partner) |
Partner (venture partner) |
Bellevue (Group) |
United Kingdom (GB) |
Harms, Carsten |
n. a. |
Eurofins (Group) |
Germany |
Harmsen, Dag (Ridom GmbH 201307 Managing Director) |
Managing Director |
Ridom GmbH |
Germany |